Tumor Infiltrating Lymphocytes (TIL) Immunotherapy

tumor-infiltrating lymphocytes

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Tumor Infiltrating Lymphocytes (TIL) Immunotherapy, covering 2017-07-24 to 2025-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer [Phase 1]

See pricing